Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
October 24th, 2018
12.3K views
Here we present a protocol describing the technique of veno-venous extracorporeal membrane oxygenation (ECMO) in a non-intubated, spontaneously breathing mouse. This murine model of ECMO can be effectively implemented in experimental studies of acute and end-stage lung diseases.
Overview
This protocol describes the technique of veno-venous extracorporeal membrane oxygenation (ECMO) in a non-intubated, spontaneously breathing mouse. This model can be effectively used in studies of acute and end-stage lung diseases.
Key Study Components
Area of Science
- Pulmonary research
- Extracorporeal membrane oxygenation (ECMO)
- Acute and chronic lung disease
Background
- ECMO is a life-saving procedure for patients with severe respiratory failure.
- This technique allows for the study of molecular and pathological mechanisms of multi-organ damage.
- Understanding these mechanisms is crucial for developing effective therapies.
- The model provides insights into the effects of prolonged ECMO on lung function.
Purpose of Study
- To establish a murine model for studying ECMO in lung disease.
- To investigate the effects of ECMO on lung and organ function.
- To facilitate research on therapeutic interventions for lung diseases.
Methods Used
- Preparation of a two French polyurethane catheter with fenestrations.
- Priming the ECMO circuit with a peristaltic pump.
- Administration of oxygen to the oxygenator.
- Visualization and cannulation of the jugular vein in the mouse.
Main Results
- The protocol successfully establishes ECMO in a non-intubated mouse model.
- Facilitates the study of lung disease mechanisms during ECMO.
- Provides a basis for future research on therapeutic strategies.
- Demonstrates the feasibility of this model for acute lung injury studies.
Conclusions
- This ECMO model is a valuable tool for pulmonary research.
- It enhances understanding of lung disease and potential treatments.
- Future studies can build on this protocol to explore various lung conditions.
Frequently Asked Questions
What is ECMO?
ECMO stands for extracorporeal membrane oxygenation, a technique used to provide oxygen to the blood when the lungs are unable to do so.
How is the ECMO model established in mice?
The model is established by cannulating the jugular vein and connecting it to an ECMO circuit that provides oxygenation.
What are the advantages of using a non-intubated mouse model?
This model allows for the study of spontaneous breathing and its effects on lung function during ECMO.
What types of lung diseases can this model help study?
It can be used to study both acute and chronic end-stage lung diseases.
What are the implications of this research?
The findings can lead to better understanding and treatment options for patients with severe lung conditions.
Executive Industry Relevance
Establishing a murine veno-venous ECMO model enables mechanistic investigation of multi-organ damage during prolonged respiratory support, a critical consideration for de-risking therapeutic strategies in acute and end-stage lung disease. This model supports target validation by allowing dissection of inflammatory, thrombotic, and bleeding pathways using genetically modified mice, thereby improving predictive confidence in preclinical pipeline decisions. The approach facilitates early discovery workflows by providing a reproducible system to evaluate intervention efficacy before advancing to larger animal or clinical studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to ECMO-induced inflammation, thromboembolism, and bleeding pathways.
- Operational Value: Supports functional target validation in disease-relevant systems using genetically modified mouse models.
- Scientific Value: Facilitates mechanistic de-risking by isolating molecular mechanisms of organ damage during extracorporeal support.
Screening & Assay Development
- Operational Value: Prepares standardized, reproducible biological systems for downstream compound or intervention screening.
- Scientific Value: Provides quantitative hemodynamic and blood gas readouts to enable reliable compound evaluation.
- Operational Value: Supports assay scalability and platform reuse across multiple experimental timepoints and interventions.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance through spontaneous breathing physiology, enhancing translational continuity from discovery to preclinical validation.
- Operational Value: Enables risk-adjusted advancement decisions by monitoring vital parameters, oxygenation, and metabolic changes over time.
- Scientific Value: Supports biomarker discovery through serial blood sampling for gas analysis, hematology, and metabolic profiling.
Pipeline & Workflow Integration
The veno-venous ECMO model integrates into early discovery workflows by establishing a disease-relevant system for hypothesis testing, pathway clarification, and biological de-risking prior to lead identification stages.
- Discovery Biology: Supports hypothesis testing of ECMO-related pathophysiological mechanisms via real-time monitoring of vital and oxygenation parameters.
- Screening: Delivers assay readiness through standardized circuit priming, stable flow rates, and reproducible blood sampling protocols.
- Analytics: Enables comparative analysis of conditions via serial blood gas analysis, hematological tracking, and metabolic change monitoring.
- Translational Research: Connects discovery findings to preclinical continuity through spontaneous breathing model and genetically tractable background.
- Enterprise Reuse: Establishes a reusable platform for evaluating multiple interventions across different genetic backgrounds and timecourse designs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in ECMO-related multi-organ damage.
- Operational Value: Ensures standardization, reproducibility, and scalability through detailed cannulation, priming, and monitoring procedures.
- Strategic Value: Improves go/no-go decisions by enabling early detection of adverse mechanisms, reducing late-stage biological risk in lung disease programs.
- Portfolio Impact: Supports risk-adjusted prioritization by providing quantitative safety and efficacy readouts for intervention evaluation.
Implementation Considerations
- Requires expertise in microsurgical techniques, including vessel cannulation and suture placement under magnification.
- Dependent on instrumentation such as peristaltic pumps, oxygenators, data acquisition systems, and microsurgical tools.
- Necessitates cross-team standardization of protocols for surgical preparation, circuit priming, and blood sampling schedules.
- Involves adaptation considerations when applying the model to different genetic backgrounds or disease models.
- Includes practical limitations related to blood sampling volume, hemodilution effects, and the need for priming solution replacement to maintain circuit integrity.
Biopharma FAQs
Why is monitoring oxygenation parameters via blood gas analysis important in veno-venous ECMO?
Monitoring oxygenation parameters via blood gas analysis confirms proper oxygenator performance and ensures adequate tissue oxygenation during ECMO support, which is critical for interpreting study outcomes related to lung function and multi-organ responses.
How does isolating the independent variable of ECMO flow rate support discovery pipeline objectives?
Isolating the independent variable of ECMO flow rate allows researchers to test the effects of varying support levels on hemodynamic stability and organ function, enabling precise hypothesis testing in preclinical target validation workflows.
What quantitative dependent variable measurements enable assessment of ECMO-induced hemodilution?
Quantitative hematological parameters, such as hemoglobin concentration and hematocrit, measured via serial blood sampling, enable assessment of hemodilution during ECMO, informing decisions on fluid management and transfusion thresholds.
Why do replication requirements for vital parameter monitoring matter in cross-functional collaboration?
Replication requirements for vital parameter monitoring ensure consistent, reproducible data across experiments, which is essential for reliable comparison between study groups and alignment across discovery, preclinical, and translational teams.
What statistical analysis capabilities are required before implementing serial blood sampling in ECMO experiments?
Statistical analysis capabilities are needed to compare pre- and post-ECMO measurements, assess trends over time, and determine significant changes in blood gas, hematological, or metabolic parameters, supporting data-driven go/no-go decisions in therapeutic development.
